anti-seizure medication + sedative agent(s)
PreclinicalSmall molecule
anti-seizure medication + sedative agent(s) is one of 26 small molecule programs targeting Coma. It is currently in Preclinical.
2
Indications
1
Total Trials
1
Active Trials
25
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
41 competitors in Status Epilepticus
#DrugCompanyPhaseTrials
1Keppra
UCBApproved
Ketalar
AAultman Health Foundation
Approved
Versed
CConrado Roberto Hoffmann Filho
Approved
Epidiolex
Jazz PharmaceuticalsApproved
Depakote
AbbViePhase 3
Vimpat
UCBPhase 3
Actemra
RochePhase 3
Luminal
BBiomed Industries, Inc.
Phase 3
Ativan
BBausch Health Americas, Inc.
Phase 3
Fintepla
IImmedica Pharma AB
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Twente